Joske Nauta

Joske Nauta

Auto-generated profile, based on publicly available information

Joske Nauta

Department of Public and Occupational Health, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
JNJoske Nauta
Joske Nauta
FNFemke van Nassau
Femke van Nassau
ABAdrie J Bouma
Adrie J Bouma
LKLeonie A. Krops
Leonie A. Krops
HPHidde P van der Ploeg
Hidde P van der Ploeg
RDRienk Dekker
Rienk Dekker
Objectives Despite the many proven advantages of a physically active lifestyle in patient populations, prescription of exercise is currently not widely implemented in routine clinical practice. The aims of this study were twofold: (1) to assess perceptions of clinicians on the current practice of exercise is medicine (E=M) prescription in two Dutch university medical centres and (2) to determine their perceived barriers and facilitators for the implementation of E=M in routine clinical care in Dutch university medical centres. Design A mixed methodologies study, using both online questionnaires and semi-structured interviews. Setting Dutch university medical centres. Participants Clinicians working within the departments of medical oncology, orthopaedics and rehabilitation medicine of two university medical centres. Results Forty-five clinicians (response rate of 51%) completed the questionnaire, and 19 clinicians were interviewed. The results showed that even though clinicians had a positive attitude towards prescribing E=M, only a few reported to regularly prescribe E=M to their patients. The 52 identified facilitators and barriers for implementation of E=M were categorised into four main themes: (1) beliefs toward the implementation of E=M (eg, clinicians knowledge and skills, and social support), (2) factors related to the patient perspective (eg, patient priorities or motivation), (3) factors related to the referral options (eg, knowledge of and trust in local referral options) and (4) practical considerations when implementing E=M (eg, time constraints). Conclusions Our study showed that even though many clinicians have a positive attitude toward an active lifestyle, many are not prescribing E=M on a regular basis. In order for clinicians to effectively implement E=M, strategies should focus on increasing clinicians E=M referral skills, improving clinicians knowledge of E=M referral options and develop a support system to ensure that E=M is high on the priority list of clinicians.

17 February 2023 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
EVEvert Verhagen
Evert Verhagen
IVIngrid Vriend
Ingrid Vriend
VGVincent Gouttebarge
Vincent Gouttebarge
Ellen KemlerEllen Kemler
Ellen Kemler
JWJacqueline de Wit
Jacqueline de Wit
JNJoske Nauta
Joske Nauta
Objectives To establish the effectiveness of the ‘VolleyVeilig’ programme on reducing injury rate, injury burden and injury severity in youth volleyball players. Methods We conducted a quasi-experimental prospective study over one season of youth volleyball. After randomisation by competition region, we instructed 31 control teams (236 children, average age 12.58±1.66) to use their usual warm-up routine. The ‘VolleyVeilig’ programme was provided to 35 intervention teams (282 children, average age 12.90±1.59). This programme had to be used during each warm-up before training sessions and matches. We sent a weekly survey to all coaches, collecting data on each player’s volleyball exposure and injuries sustained. Multilevel analyses estimated differences in injury rates and burden between both groups, and we used non-parametric bootstrapping to compare the differences in injury numbers and injury severity. Results We found an overall reduction in injury rates of 30% for intervention teams (HR 0.72; 95% CI 0.39 to 1.33). Detailed analyses revealed differences for acute (HR 0.58; 95% CI 0.34 to 0.97) and upper extremity injuries (HR 0.41; 95% CI 0.20 to 0.83). Compared with control teams, the intervention teams had a relative injury burden of 0.39 (95% CI 0.30 to 0.52) and a relative injury severity of 0.49 (95% CI 0.03 to 0.95). Only 44% of teams fully adhered to the intervention. Conclusion We established that the ‘VolleyVeilig’ programme was associated with reduced acute and upper extremity injury rates and lower injury burden and severity in youth volleyball players. While we advise implementation of the programme, programme updates to improve adherence are needed.

2 November 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
LKLeonie A. Krops
Leonie A. Krops
ABAdrie J. Bouma
Adrie J. Bouma
FNFemke Van Nassau
Femke Van Nassau
JNJoske Nauta
Joske Nauta
IAInge van den Akker-Scheek
Inge van den Akker-Scheek
RDRienk Dekker
Rienk Dekker
Background: The prescription of physical activity (PA) in clinical care has been advocated worldwide. This “exercise is medicine” (E=M) concept can be used to prevent, manage, and cure various lifestyle-related chronic diseases. Due to several challenges, E=M is not yet routinely implemented in clinical care. Objective: This paper describes the rationale and design of the Physicians Implement Exercise = Medicine (PIE=M) study, which aims to facilitate the implementation of E=M in hospital care. Methods: PIE=M consists of 3 interrelated work packages. First, levels and determinants of PA in different patient and healthy populations will be investigated using existing cohort data. The current implementation status, facilitators, and barriers of E=M will also be investigated using a mixed-methods approach among clinicians of participating departments from 2 diverse university medical centers (both located in a city, but one serving an urban population and one serving a more rural population). Implementation strategies will be connected to these barriers and facilitators using a systematic implementation mapping approach. Second, a generic E=M tool will be developed that will provide tailored PA prescription and referral. Requirements for this tool will be investigated among clinicians and department managers. The tool will be developed using an iterative design process in which all stakeholders reflect on the design of the E=M tool. Third, we will pilot-implement the set of implementation strategies, including the E=M tool, to test its feasibility in routine care of clinicians in these 2 university medical centers. An extensive learning process evaluation will be performed among clinicians, department managers, lifestyle coaches, and patients using a mixed-methods design based on the RE-AIM framework. Results: This project was approved and funded by the Dutch grant provider ZonMW in April 2018. The project started in September 2018 and continues until December 2020 (depending on the course of the COVID-19 crisis). All data from the first work package have been collected and analyzed and are expected to be published in 2021. Results of the second work package are described. The manuscript is expected to be published in 2021. The third work package is currently being conducted in clinical practice in 4 departments of 2 university medical hospitals among clinicians, lifestyle coaches, hospital managers, and patients. Results are expected to be published in 2021. Conclusions: The PIE=M project addresses the potential of providing patients with PA advice to prevent and manage chronic disease, improve recovery, and enable healthy ageing by developing E=M implementation strategies, including an E=M tool, in routine clinical care. The PIE=M project will result in a blueprint of implementation strategies, including an E=M screening and referral tool, which aims to improve E=M referral by clinicians to improve patients’ health, while minimizing the burden on clinicians.

1 January 2026 in BMJ Open Sport & Exercise Medicine
Verified
Journal Article
Open access
PDF file
JNJoske Nauta
Joske Nauta
JHJelena Haugg
Jelena Haugg
RNRico Németh
Rico Németh
EVEvert Verhagen
Evert Verhagen
CMCarly D McKay
Carly D McKay
FNFemke van Nassau
Femke van Nassau
There is a gap between the evaluation of injury prevention programmes in controlled trials and their use in real-world practice, and implementation research seeks to bridge this gap by supporting programme uptake beyond research settings. This study explored implementation processes and influencing factors during and after effectiveness trials of injury prevention programmes, and examined strategies used for scale-up following trials. Using a mixed methodologies design, corresponding authors of published injury prevention trials were contacted and invited to complete a survey on implementation activities conducted during their trial and, where applicable, during scale-up. A subsample of respondents also participated in semi-structured interviews. In total, 107 injury prevention studies were identified, of which 39 authors completed the survey and nine took part in interviews. Implementation strategies applied during trials were often underreported in published studies but were identified through the survey, with common strategies including in-person training, staff education, and the provision of supportive materials. Only approximately one-third of the studies resulted in scale-up beyond the trial context. Survey responses and interview data highlighted several facilitators and barriers relevant to both trial implementation and scale-up, such as programme context, coach and athlete motivation, and organisational support. Other factors were phase-specific: trial implementation benefited from structured programme development and close researcher involvement, whereas scale-up was more strongly influenced by limited resources and external momentum, such as public events. These findings suggest that to enhance implementation and scale-up of injury prevention programmes, implementation factors should be considered throughout both the development and evaluation phases. Systematic reporting and assessment of facilitators and barriers during trials and broader scale-up initiatives, along with transparent descriptions of implementation strategies used in effectiveness studies, are essential to improve the translation of research findings into practice.

30 June 2021 in BMJ Open Sport & Exercise Medicine
Verified
Journal Article
Open access
PDF file
EVEvert Verhagen
Evert Verhagen
FOFabio Oliveira
Fabio Oliveira
OAOsman Hassan Ahmed
Osman Hassan Ahmed
NANash Anderson
Nash Anderson
MBMarelise Badenhorst
Marelise Badenhorst
TPtej pandya
tej pandya

10 May 2025 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
SLSietske Cm Luijten
Sietske Cm Luijten
SJSimone Cn Jenniskens
Simone Cn Jenniskens
JHJasmijn Fm Holla
Jasmijn Fm Holla
TJThomas Wj Janssen
Thomas Wj Janssen
JNJoske Nauta
Joske Nauta
EVEvert Verhagen
Evert Verhagen
Objective: This randomised controlled trial evaluated the efficacy of the Tailored Injury Prevention in Adapted Sports (TIPAS) intervention on sports-related health problems in athletes participating in adaptive sports with physical impairments. Methods: We randomly assigned 60 athletes participating in adaptive sports with physical impairments to an intervention group and 47 to a control group. The intervention group received direct, automated, predetermined preventive and management measures tailored to their weekly reported health problems, physical impairments and sports. The primary outcome was injury and illness prevalence over 40 weeks. Secondary outcomes were incidence, weekly cumulative severity score, weekly time loss, and total burden. A multinomial mixed methods analysis was performed to identify an intervention effect over time. Results: The athletes (53 women, 54 men; age±45 years) reported 449 health problems (162 illnesses, 287 injuries) during the study period. The overall prevalence of health problems was 44% in the intervention group and 46% in the control group. Over time, no significant main intervention effect was found (illnesses OR: 1.02; 95% CI: 0.52 to 1.99; and injuries OR: 1.01; 95% CI: 0.55 to 1.86). However, a significant positive time×group interaction effect (p<0.001) indicated a reduction in injury prevalence in the intervention group over time, though not for illnesses. The rates versus severity analysis showed a significantly lower illness severity in the intervention group relative to the control group. Conclusion: The TIPAS intervention provides a non-significant decrease in the overall prevalence of sport-related injuries and illnesses and may reduce the severity of sport-related illnesses throughout a Dutch sports season. This tailored online preventive strategy provides an accessible programme to consider in adapted sports suited to athletes’ physical impairments, sports participation and current health status. Trial registration number : ICTRP register: NL-OMON24078